Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%

Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery

The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.

Reforgene Completes Pre-B Round Financing of CNY Hundreds of Millions

EqualOcean learned that Reforgene Medicine (瑞风生物) recently announced the completion of Pre-B round financing of CNY hundreds of millions.

Joe Future Food Completes A+ Round Financing of CNY Tens of Million

Cell-Cultured Meat Leader, Joe Future Food (周子未来), completes A+ round financing of CNY tens of million.

Tripod, the New CRO, Completes C Round Financing of RMB Hundreds of Mn

Tripod Preclinical Research Laboratories Co., Ltd. (鼎泰集团) announced the completion of C round financing of RMB hundreds of million.

HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D

Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.